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The First 11 Years of Department of Neurology in Toyama University Hospital.
Kortaro TANAKA
Koganei rehabilitation hospital, Emeritus professor of Toyama University
和文要旨
　富山大学附属病院神経内科は，２００５年 6 月１6日に田中耕太郎が初代教授として赴任したことで開設さ
れ，同年 6 月２７日から入院患者の受け入れを開始し， ７ 月 １ 日から外来診療を毎日おこなうようになっ











　Department of neurology in Toyama university hospital was founded on June １6, ２００５ by Prof. 
Kortaro Tanaka, M.D., Ph.D. as the first chairperson. At the beginning, the faculty consisted of only ３ 
neurologists and １ student of graduate medical school. Today, the department has grown to include 
over １０ full-time and associated doctors with a full range of clinical activities, research and education 
of medical students, residents, and fellows. Our neurologists are experts in the wide range of neurologic 
disorders, treating the most common ones such as stroke, Parkinson’s disease, dementia, migraine and 
so on as well as those that are rare. Our department has become the major neurological center in 
Hokuriku area for various disorders affecting the brain, spinal cord, peripheral nerves and muscles. I 
hope that many young doctors will become part of our department family to get the excellent training 
and pursue various careers in clinical neurology and research. 
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たい」という私の談話が紹介された。２００５年 ７ 月 １ 日か


















　体制作りの一環として，２００５年 8 月 １ 日付けで第二内
科助手の田口芳治先生を神経内科助手に配置換え，２００５


















神経内科の規模は，「教授 １ 名，助教授 １ 名，助手 １ 名」
の ３ 名となっていた。この公募文書を私は全く見ていな
かったが，その ５ 日後の 8 月３１日付けで，同じく小林　
正先生の名前で，当時慶應義塾大学に勤務していた私に
直接同様な公募文書が郵送されて来た。そこには，平成









規模は，「教授 １ 名，助教授 １ 名，助手 １ 名」の ３ 名で
あることが判明し，だいぶ落胆した記憶がある。 ３ 名と
4 名のたった １ 名の違いと思われるかもしれないが，後
で記すように，大学全体の厳しい人員削減の方針の中
で，常勤医師（教員）の定員数を増やすことは至難の業

























































脳卒中 １０１ ７6 ７７
パーキンソン病 4０ ２8 ３6
パーキンソン症候群 ５ １０ １５
脊髄小脳変性症 8 ９ ２０
筋萎縮性側索硬化症（ALS） １３ １３ ２０
その他の神経変性疾患 ５ １ １２
認知症 １０ ２ ３
神経免疫疾患 １５ ３０ ３０
末梢神経疾患 １4 １２ １５
筋疾患 ９ １３ ２０
神経感染症 ７ １０ １２
てんかん １９ １１ １５
代謝性神経障害 １０ ０ １０
その他 4２ ３７ １6
（名）
図 1　富山大学附属病院神経内科の外来・入院患者数の変化（2005年～2014年度）
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育への貢献度から，他診療科並みに常勤医師数を現状の





































































































































































５ ）Hirano K, Takashima S, Dougu N, Taguchi Y, Nukui T, 
Konishi H, Toyoda S, Kitajima I, Tanaka K: Study of 
hemostatic biomarkers in acute ischemic stroke by 
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２０１6年 6 月から医学研究棟 ７ 階に引っ越しができて，よ
うやく研究実験室（ラボ）や冷蔵冷凍庫保管室ができ，
研究環境は整ってきた。有効な活用を期待したい。　



















月 ３ 日），第２５３回北陸外科学会会長（平成１4年 ９ 月 ７
日），第３２回日本小児外科学会北陸地方会会長（平成１4
年 ９ 月 ７ 日），第３０回日本膵切研究会会長（平成１５年 ５
月１4日～１6日），第8１回日本消化器内視鏡北陸地方会会
長（平成１５年 6 月２２日），第１３回日本消化器内視鏡学会
北陸セミナー会長（平成１７年 ２ 月 ５ 日），第２6２回北陸外
科学会会長（平成１９年 ９ 月 8 日），第３6回日本小児内視
鏡研究会会長（平成２１年 ７ 月 4 日），第46回日本腹部救
急医学会総会会長（平成２２年 ３ 月１8日～１９日），第１７回
日本門脈圧亢進症学会総会会長（平成２２年 ９ 月 ９ 日～１０
日），第6７回日本消化器外科学会総会会長（平成２4年 ７
月１７日～１９日），第 １ 回日本臨床外科学会富山支部会会

























Review:  Achievement of Dr. Kazuhiro Tsukada
Takuya Nagata
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fibroblast-like features, characterized by increased cell 
proliferation, motility, contractility and the production 
of extra-cellular matrix1), 2).  Activation of HSCs is regu-
lated by several cytokines and growth factors, includ-
ing platelet-derived growth factor (PDGF), a most po-
tent mitogen for HSCs3).
　PDGF family members, PDGF-A, -B, and newly dis-
1.Introduction
　Hepatic fibrosis is a common response to chronic liv-
er insults such as ethanol, viral infection, cholestasis and 
metabolic disease.  One of the hallmarks of hepatic fi-
brosis is the activation of hepatic stellate cell (HSCs). 
Following liver injury of any etiology, HSCs undergo 
phenotypic transformation with the acquisition of myo-
原　　　著
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　Background/Aims: Platelet-derived growth factor (PDGF) is implicated in the activation of hepatic 
stellate cells (HSCs), the key cell population in liver fibrogenesis.  We depleted the expression of PDGF 
receptor-ß (PDGFR-ß) and assessed the role in the activation of HSCs.  Methods: We used the wild-
type and mutant mice whose PDGFR-ß gene was flanked by two loxP sequences, and isolated/cul-
tured HSCs from these two mice, respectively.  These cells were infected with Cre recombinase-ex-
pressing adenovirus.  Results: After Cre-adenovirus infection, PDGFR-ß expression was depleted in 
HSCs from mutant mice (PDGFR-ß∆/∆), but was preserved in those from wild-type.  We detected the 
expression of PDGFR-α and PDGF-A, -B, -C, and -D at similar levels between WT and PDGFR-ß∆/∆. 
BrdU-incorporation in PDGFR-ß∆/∆ was suppressed in serum-starved/non-stimulated and PDGF-BB 
stimulated conditions, respectively. PDGF-BB-induced wound closure was apparently delayed in PDG-
FR-ß∆/∆.  α１ (I) collagen mRNA was low in PDGFR-ß∆/∆, sparing α-smooth muscle actin mRNA at WT 
levels.  Conclusions: The HSCs expressed two types of PDGFR; however, PDGFR-ß was distinctively 










Key words: liver fibrosis, liver stellate cell, platelet-derived growth factor, Cre recombinase, autocrine
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the PDGF system in liver fibrosis.
2.Materialsandmethods
2.1.Animals
　The F1 progenies, carrying a recombinant allele of 
PDGFR-ß (PDGFR-ßflox/+), were generated previously18), 
and were crossbred with wild-type C57BL/6 mice 5 
times.  Then, we obtained homozygous mutants (PDG-
FR-ßflox/flox) by sister-brother inbreeding.  All animals 
received animal care according to the Institutional Ani-
mal Care and Use Committee at University of Toyama.
2.2.IsolationandcultureofmouseHSCs
　The HSCs were isolated from mice of 4 to 5-months-
old by perfusion of collagenase (Rosche Applied Science, 
Indianapolis, IN) and pronase (Wako Pure Chemical Co., 
Osaka, Japan), followed by centrifugation over Nyco-
denz gradient (Nycomed Pharma AS, Oslo, Norway), as 
described previously19).  After isolation, the cells were 
plated at a density of 2 x 105 cells/35 mm plastic dish 
and were cultured in Dulbecco’s modified Eagle’s medi-
um (DMEM, Nissui Pharmaceutical Co., Ltd., Tokyo, Ja-
pan), supplemented with 10% Fetal Bovine Serum (FBS, 
BioWhittaker A Cambrex Inc., Walkerville, MD) and 
antibiotics (105 U/l penicillin G, 100mg/l streptomycin). 
HSCs were identified by the typical star-like configura-
tion and vitamin A autofluorescence, and the purity 
was higher than 99%.
2.3.Adenovirus
　Cre expressing adenovirus, AxCANCre, was gener-
ously provided by Dr. Izumu Saito (University of To-
kyo, Japan)20) and RIKEN, BioResource Center (Ibaraki, 
Japan).  Cre recombinase was transfected into HSCs by 
AxCANCre as described previously18).  The HSCs were 
infected on day 1 of culture.
2.4.Westernblotting
　Proteins were prepared from HSCs cultured in 
DMEM supplemented with 10% FBS from days 2 to 8. 
In other experiments, proteins were prepared from 
HSCs stimulated for 10 min by PDGF-BB (10 ng/ml; 
Invitrogen, Carlsbad, CA) after 24 h-starvation within 
DMEM supplemented with 0.5% FBS.  The preparation 
of protein lysates, Western-blotting and following detec-
tion procedures were performed as described previous-
ly18), 21).  A total of 5 µg of protein was run on each lane 
and was blotted with the antibodies, as listed in table 1.
covered PDGF-C, and -D, are assembled as disul-
fide-linked homo- or heterodimers and exert their activ-
ity by binding to and activating specific high affinity 
cell surface receptors4)-7).  Two receptor tyrosine kinas-
es, PDGFR-α and -ß, that can form homo- and heterodi-
meric receptor complexes have been identified.  The 
PDGFR-αα can be specifically activated by PDGF-AA, 
-AB, -CC and -BB; PDGFR-αß by PDGF-AB, -BB and 
-CC; PDGFR-ßß by PDGF-BB and -DD.  Depending of 
the cell type, these ligands and receptors are expressed 
at various levels and function in paracrine and auto-
crine mechanisms8).
　It has been reported that PDGF-A and -B and PDG-
FR-α and -ß are upregulated in both human cirrhotic 
liver tissues and experimental rat liver fibrosis9)-11).  The 
induction of PDGFR-ß expression is assumed to be an 
early event in HSC activation in vitro and in vivo and 
to be a crucial initiation step of liver fibrosis11)-13).  Based 
on these reports, several therapeutic trials to inhibit the 
PDGF system have been successfully conducted to pre-
vent experimentally induced liver fibrosis13)-15).  On the 
other hand, the hepatic overexpression of either 
PDGF-B or PDGF-C by a transgenic strategy was re-
cently reported to induce liver fibrosis16),17).  The in-
volvement of PDGFR-α as well as PDGFR-ß is necessary 
for the pathogenesis of PDGF-CC induced liver fibrosis, 
because PDGF-CC binds to PDGFR-αα and -αß but not 
-ßß.  Thus, the multiple PDGF ligands and receptors are 
involved and are assumed to be important for the liver 
fibrogenesis; however, the precise mechanism still re-
mains unknown.
　Previously, we established a PDGFR-ßflox/flox mouse 
line in which two loxP sequences are inserted into the 
intron of the PDGFR-ß genomic sequence, and selective-
ly depleted PDGFR-ß in cultured dermal fibroblasts by 
Cre-transfection18).  PDGFR-ß depleted fibroblasts 
showed decreased migratory and proliferative respons-
es that are important for the wound healing of the skin. 
Our data on these cells indicated a distinctive role of 
PDGFR-ß that differs from PDGFR-α.
　Although the HSCs are known to express both PDG-
FR-α and -ß mRNA12), the functional role of each recep-
tor in this specific cell type is yet to be determined.  In 
the present study, we isolated HSCs from PDGFR-ßflox/
flox mouse, and selectively depleted their PDGFR-ß ex-
pression by introducing Cre recombinase using an ade-
novirus-vector.  Then, we sought to determine the dis-
tinctive role of PDGFR-ß in the activation process of 
HSCs, for the clarification of the functional relevance of 
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followed by 40 cycles at 95˚C for 10 sec and 60˚C for 40 
sec.  The threshold cycle values were calculated, and 
transcript levels were then standardized against GAP-
DH levels.  Sequences of the primers are listed in Table 
2.  The average efficiency of all PCR reactions was more 
than 90%.
2.7.Proliferationassay
　Proliferative activity was measured by nuclear label-
ing of HSCs with 5-bromo-2’-deoxyuridine (BrdU) on the 
indicated days.  The HSCs were serum-starved in 
DMEM supplemented with 0.5 % FBS for 24 h, then 
HSCs were incubated with BrdU (10 mmol/l) and with 
or without 10 ng/ml of PDGF-BB in starvation medium 
for another 24 h.  BrdU-incorporation was detected ac-
cording to the manufacturer’s instructions (BrdU detec-
tion kit I, Roche Diagnostics GmbH).  The proportion of 
BrdU- positive nuclei was calculated by counting at 
least 500 cells in the specified number of independent 
2.5.Immunofluorescentstaining
　HSCs cultured on 4-well chamber glass slides were 
fixed with cold acetone for 10 min on day 2-8, and im-
munostained for PDGFR-ß and α-smooth muscle actin 
(α-SMA) using antibody listed in Table 1.  Detection and 
visualization were previously described18), 21).
2.6.RNAisolationandRT-PCRforPDGF-ligands,col-
lagen,andα-SMA
　Total RNA was isolated using a RNeasy mini kit (Qia-
gen, Hiden, Germany) from HSCs on the indicated days, 
and 0.2 µg of RNA was reverse transcribed using Ex-
Script RT reagent Kit (TAKARA, Shiga, Japan) accord-
ing to the manufacturer’s instructions.  The expression 
of PDGF-A, -B, -C, -D, α1 (I) collagen, α-SMA, and GAP-
DH mRNA was evaluated by quantitative RT-PCR anal-
ysis using the SYBR Premix Ex Taq (TAKARA) and 
Mx3000P (Stratagene, La Jolla, CA).  All reactions were 
run in triplicate with an initial 10 sec activation at 95˚C, 
Table1　PrimaryantibodiesforWesternblottingandimmunofluorescentstaining
Table2　ForwardandreverseprimerusedforrealtimePCRanalysis




　We first investigated whether Cre-expressing adeno-
virus infection could abrogate the expression of PDG-
FR-ß in HSCs isolated from PDGFR-ßflox/flox mice.  On 
Western blots, cultured HSCs isolated from wild-type 
mice expressed PDGFR-α and -ß at all time points ex-
amined, and most abundantly on day 2 (Fig. 1A).  The 
expression of PDGFR-ß was undetectable in HSCs iso-
lated from PDGFR-ßflox/flox mice after Cre transfection, 
and we designated these HSCs depleted in PDGFR-ß 
expression as PDGFR-ß∆/∆.  The expression of PDGFR-α 
in PDGFR-ß∆/∆ HSCs was at similar levels to that in 
wild-type.  In immunofluorescent analyses, most of the 
wild-type HSCs were labeled for PDGFR-ß throughout 
the experimental periods, most intensely on day 2 (Fig. 
1B).  The immunoreactivities for PDGFR-ß disappeared 
in almost all of HSCs isolated from PDGFR-ßflox/flox mice 
experiments.
2.8.Woundscratchassay
　HSCs were cultured in uncoated 12-well plastic plates 
in DMEM supplemented with 10% FBS, allowing them 
to reach a sub-confluent state.  After serum-starvation 
for 24 h, the cells were scratched with a 100 µl plastic 
pipette tip.  Then, the cells were cultured in DMEM 
supplemented with 10 ng/ml PDGF-BB, and the wound 
closure was observed after 48 h using an inverted phase 
contrast microscope (Olympus CK30) and photographed.
2.9.Statisticalanalysis
All values are presented as means ±S.E.M.  ANOVA 
and Student’s t test were used to determine the p val-








(blue). Eachfigurewaspreparedat the samemagnification. Scalemicronbar
represents50µm.Representativeimmunofluorescentstainingisshown.
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tively high in serum-starved and unstimulated condi-
tion on days 4, 6 and 8, and in a small percentage of cells 
on day 10 (Fig. 3).  In wild-type HSCs, PDGF-BB stimu-
lation significantly enhanced BrdU-incorporation on 
days 6 and 8, but not on days 4 and 10.
　In PDGFR-ß∆/∆ HSCs, the percentage of BrdU-incorpo-
ration in serum-starved and unstimulated condition was 
extremely low on days 4 and 10 compared to that in 
days 6 and 8 (Fig. 3).  In these conditions, the percent-
age of BrdU-positive cells was significantly lower in 
PDGFR-ß∆/∆ HSCs than in wild-type HSCs on days 4 and 
6.  PDGF-BB stimulation did not enhance BrdU-incorpo-
ration in PDGFR-ß∆/∆ HSCs throughout the experiment.
3.4.PDGFR-ßdepletionattenuatedPDGF-BBinduced
cellmigrationofHSCs
　The effect of PDGFR-ß depletion was elucidated on 
the closure of a scratched wound in vitro.  In this assay, 
PDGF-BB induced the migration of wild-type HSCs, re-
sulting in complete wound closure 48 h after scratching 
(Fig. 4A and 4B).  In the same conditions, the migratory 
response in PDGFR-ß∆/∆ HSCs was quite limited com-
after Cre transfection throughout the experimental pe-
riods (Fig. 1B).
　Both wild-type and PDGFR-ß∆/∆ HSCs survived and 
showed activated phenotypes typical to HSCs in vitro: 
both types of cells enlarged, became polygonal in shape, 
and showed increased immunoreactivity for α-SMA as 
a function of culture duration (Fig. 1C).
3.2.AllPDGF-ligandswereendogenouslysynthesized
inHSCs.
　The mRNA expression levels of four PDGF-ligands 
(PDGF-A, -B, -C, and -D) were elucidated by quantita-
tive RT-PCR (Fig. 2).  The mRNA of all four ligands was 
detected on days 4 and 8, and there was no significant 
difference in the levels of mRNA expression between 
the two types of HSCs.
3.3.PDGFR-ßdepletiondecreasedDNAsynthesisof
HSCs
　The effect of PDGFR-ß depletion was elucidated 
through the mitogenic activity of HSCs.  In wild-type 
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er in PDGFR-ß∆/∆ HSCs on day 6; however, there was no 
significant difference between the two types of HSCs 
throughout the experiment.
4.Discussion
　The present study was conducted to clarify the func-
tional relevance of PDGFR-ß in the activation of HSCs, 
which is a central phenomenon of liver fibrogenesis.
　PDGFR-ß expression is upregulated at day 1 in HSCs, 
and decreased to normal levels at days 7-12 after liver 
injuries induced by CCl4 administration or by bile duct 
ligation11).  In the present study, PDGFR-α and -ß were 
expressed abundantly during the early days of culture, 
and decreased afterwards in wild-type HSCs.  Cre 
transfection selectively depleted PDGFR-ß in PDG-
FR-ßflox/flox HSCs without affecting the expression of 
PDGFR-α.  Through the culture periods, our wild-type 
and PDGFR-ß∆/∆ HSCs showed the morphologic features 
typical to the transdifferentiation into myofibroblast-like 
cells, such as loss of fat droplets, increased cytoplasmic 
extensions, and α-SMA expression22).  Taken together, 
our culture system seems to reproduce the early activa-
tion process of HSCs after liver injury, and allowed us 
to analyze the role of PDGFR-ß in the activation of 
HSCs in liver fibrosis.
　PDGF is the most potent mitogen for HSCs3).  In our 
study, PDGF-BB significantly induced the BrdU-incor-
poration in wild-type HSCs but not in PDGFR-ß∆/∆ HSCs. 
pared to the wild-type, and the scratched wound re-
mained unclosed after 48 h (Fig. 4C and 4D).
3.5.PDGFR-ßdepletiondecreasedcollagenbutnot
α-SMAsynthesisinHSCs
　The effects of PDGFR-ß depletion on the expression 
of α 1(I) collagen and α-SMA genes, were elucidated, as 
indices of fibrogenesis and myofibroblastic differentia-
tion of HSCs, respectively.  In wild-type HSCs, α 1(I) 
collagen mRNA was expressed at low levels on day 2, 
as shown by real-time RT-PCR analysis (Fig. 5).  After-
wards, the corresponding mRNA increased linearly in 
these cells until day 8.
　In PDGFR-ß∆/∆ HSCs, the time course of α 1(I) collagen 
mRNA expression was significantly different from wild-
type as confirmed by the ANOVA-test for interaction 
between time and genotype (p = 0.012).  The gene ex-
pression in PDGFR-ß∆/∆ was low on day 2 and increased 
on day 4, at similar levels to those detected in wild-type 
HSCs (Fig. 5A).  Afterwards, α 1(I) collagen gene expres-
sion level in PDGFR-ß∆/∆ was significantly lower on days 
6 (p = 0.030) and 8 (p = 0.012) compared to wild-type 
HSCs.
　In both types of HSCs, α-SMA gene expression was at 
low levels on day 2 and tended to increase afterwards 
(Fig. 5B).  This tendency was similar to the findings 
obtained in the immunofluorescence staining analysis of 
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one of the specific targets regulated by PDGFR-ß be-
cause the expression of α-SMA was not affected.
　Within the therapeutic trials against liver fibrosis, 
PDGF is one of the most important targets to prevent 
HSC activation1).  Imatinib mesylate decreased rat HSC 
proliferation13) and reduced rat liver fibrosis14).  Neutral-
ization of PDGF activity, by ligand antagonists or recep-
tor blockade, prevented experimentally induced liver 
fibrogenesis27), 28), 15).  The distinctive role of PDGFR-ß in 
HSCs, demonstrated in the current study, was strongly 
supportive for these therapeutic trials targeting 
PDGF-B in liver fibrosis.  It is noteworthy that PDG-
FR-ß depletion is potentially preventive against PDGF-C 
induced liver fibrosis as well, because PDGF-CC binds 
PDGFR-αß and HSCs express PDGFR-α and -ß12), 17).
　In summary, we analyzed the early activation pro-
cesses of primary cultured HSCs in which selective 
PDGFR-ß depletion was induced by genetic manipula-
tion based on Cre loxP system.  These cells showed 
morphological features indicating transdifferentiation to 
myofibroblastic cells.  However, they showed much low-
er activity to proliferate, migrate and express the colla-
gen gene.  The distinctive role of PDGFR-ß was demon-
strated for the activation of HSCs, and it was suggested 
this receptor could be a promising target for the pre-
vention and cure of liver fibrogenic disease that seems 
to be induced by PDGF-B and/or PDGF-C.
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療 法 は 心 理 学 的 療 法 のみしかないのが 現 状 であり，
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Identification of brain regions that regulate CS-US association of contextual fear memory.
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和文要旨





経 過 に 依 存 して 変 化 するArc（activity-regulated cytoskeleton-associated protein）RNAの 局 在 を 
catFISH （cellular compartment analysis of temporal activity using fluorescence in situ 
hybridization）法により検出することで恐怖記憶連合時にCSとUSに応答し，連合に関わる脳領域を検
索した。そして，我々はCSとUSに応答し，連合が生じる際にCSおよびUSの両方の情報を持つ神経細
胞が増加する脳領域として，扁桃体の基底外側核（Basolateral Amygdala），海馬のCA １ ，嗅内皮質




　The association of contextual fear memory (CS-US association) occurs when a conditioned stimulus 
(CS) is paired with an unconditioned stimulus (US). When the association occurs, many brain regions 
are thought to be inter-connected each other and form a complex network. Thus, CS-US association 
may occur in many brain regions that receive convergent CS and US inputs. In this study, we employed 
a behavioral paradigm, context-pre-exposure facilitation effect (CPFE) paradigm, in which mice 
received paired or unpaired presentations of the CS and US during conditioning. Using this behavioral 
paradigm, we performed Arc catFISH analysis to detect brain regions required for the CS-US 
association and found that basolateral amygdala, hippocampal CA１, prefrontal cortex, piriform cortex, 
entorhinal cortex, anterior cingulate cortex, ectorhinal cortex, sensory cortex, visual cortex, and 
retrosplenial cortex that responded to CS-US signals. Furthermore, we found that the number of CS-
US responsive neurons significantly increased in basolateral amygdala, CA１, prefrontal cortex, piriform 
cortex, and entorhinal cortex of paired group. These results suggest that these brain regions regulate 
the CS-US association of contextual fear memory.
Key words: Contextual fear conditioning, CS-US association, Brain regions, CatFISH





























































30 分 24 時間
連合群
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嗅 外 皮 質（Ectorhinal cortex）， 感 覚 皮 質（Sensory 
cortex），視覚皮質（Visual cortex），さらに脳梁膨大後
部皮質（Retrosplenial cortex） ではArc RNAの局在は
核および細胞質で観察され，これら領域はCSおよびUS




















より２０mの 凍 結 切 片 を 作 製 し，catFISH法７，8）により
Arc RNAを 検 出 し，その 細 胞 内 局 在 を 調 べた（図
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梨状皮質など，多くの脳領域と繋がりを持つことが報告
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い，１０％fetal bovine serum （FBS） 含有ダルベッコ変法




２ ）NEAPP 照 射 装 置（図 １ ）： プ ラ ズ マ はPlasma 
Generator（NUグローバル 社 製， 名 古 屋） により
９ kV，１９kHz/6０Hzで 発 生 させ，ヘリウムガス（ ２ L/
min）を流しながら照射を行った。
３ ）実 験 手 順：９6-well plateにMG-6３ 細 胞 を ５ ×１０３ 







た。しかし，近 年，常 温 の 非 平 衡 大 気 圧 プラズマ













Cell growth inhibition by nonequilibrium atmospheric pressure plasma (NEAPP) on the 
cultured osteosarcoma cells
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和文要旨






　Nonequilibrium atmospheric pressure plasma (NEAPP) has been focused as a cancer therapy, 
recently. We applied NEAPP on the cultured human osteosarcoma MG-6３ cells. The cell growth was 
inhibited by direct effects of NEAPP compared with control group assessed by CCK-8 (p<０.０５). The 
viable cells decreased time-dependently, and showed cell death phenomenon until 8 hours. On the 
other hand, the growth-inhibition was not observed in the indirect-NEAPP group, which was exposed 
medium-only.
Key words: plasma medicine, osteosarcoma, malignant tumor





















１２０秒 間 行 い，前 培 養 されたMG-6３細 胞 の 培 養 液 と
NEAPP照射された培養液を交換した（間接照射）。照射
後48時間培養してから，Cell Counting Kit- 8 （CCK- 8 ）
（同仁科学研究所，熊本）を用いて細胞増殖能を測定し
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A case of Vibrio vulnificus  infection cured promptly without a skin lesion
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　A 6７-year-old male was admitted to our hospital due to shaking chills and high fever on a summer 
day after having eaten raw fish on the previous day to admission. Promptly after antibiotics were 
administered to the patient, he recovered in a few days without symptoms of shock or necrotizing 
fasciitis. Classically, Vibrio vulnificus infections are considered life-threatening as they are associated 
with high mortality and thought to often affect immunosuppressed patients such those with liver 
cirrhosis. However, ours is a rare case having no signs of liver cirrhosis or immunosuppressive trouble. 
A precise picture of the course of Vibrio vulnificus infections should be developed through collecting 
and analyzing more cases including mild ones such as the one discussed here. Additionally, this is the 
first Vibrio vulnificus infection case ever reported in Toyama Prefecture.
Key words: Vibrio vulnificus，敗血症（septicemia），軽症例（mild case），血液培養（blood culture）















































養を ３ セット採取した。翌日，血液培養ボトルの 6 本中
５ 本からグラム陰性桿菌が検出され，入院とし，エンピ
リカルにタゾバクタム・ ピペラシリン4.５gを 8 時 間 毎
に投与した。経胸壁心エコーで疣贅は認めなかった。第
３ 病日には体温が３6℃台に解熱し，全身状態の回復がみ





















人数（n） 死亡（n） 死亡率（%） 皮疹出現率（%）
　　合計 ９０ 4３ 4７.8 ９０.０
　　　男性 ７8 4１ ５２.6 8９.７ 
　　　女性 １２ ２ １6.７ ９１.７ 
（性別不明の ２ 名を除く）
基礎疾患別内訳 人数（n） 死亡（n） 死亡率（%）
　　　肝障害 6１ ３6 ５９.０















１ ）Koenig KL, Mueller J, Rose T. Vibrio vulnificus-Hazard 
on the half shell. West J Med. １５５: 4００-4０３, １９９１.
２ ）Chiang SR, Chuang YC. Vibrio vulnificus infection: 
clinical manifestations, pathogenesis, and antimicrobial 
therapy. J Microbiol Immunol Infect. ２００３; ３6: 8１-88, 
２００３.
３ ）大石浩隆, 浦由紀子, 三溝慎次, 他. わが国におけるVibrio 























Toyama Medical Journal　Vol. 27　No. 1 　201636
drome. Epidemiol Infect. １３２: ９９３-９９6. ２００4.
6 ）Po-Ren Hsueh , Ching-Yih Lin, Hung-Jen Tang, Synop-







１8年 ５ 月３１日）厚 生 労 働 省. http://www.mhlw.go.jp/
topics/bukyoku/iyaku/syoku-anzen/qa/０6０５３１-１.htm　
（参照　２０１6/０３/３１）
５ ）Osaka K, Komatsuzaki M, Takahashi H, et al. Vibrio 
vulnificus septicaemia in Japan: an estimated number 

































A case of revascularization in a child with claudication and lower left and right limb length 
discrepancy due to iatrogenic ileac artery occlusion in infancy
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要　　旨
　症例は ９ 歳男児。乳児期のカテーテル治療で左外腸骨動脈を損傷し修復術が行われた。 １ 歳児の血管





　The patient was a ９-year-old boy. He was injured during a catheterization procedure performed in 
infancy that was treated with surgical repair. Angiography performed at the age of １ year revealed 
occlusion of the left external ileac artery, the progress of which was observed. At the age of ５ years, 
intermittent claudication appeared, which worsened at the age of ９ years. At the same time, the 
patient was found to have lower left and right limb length discrepancy (LLD). A revascularization 
procedure was performed using an autologous vein. The claudication disappeared post-surgery. By 4 
years post-surgery, the lower left and right limb length discrepancy had diminished. Proactive 
revascularization was useful in the development of the child in the present case.
Key words: arterial reconstruction for children, iatrogenic vascular injury, Limb-length discrepancy
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　近 年 胸 部 大 動 脈 瘤 に 対 するステントグラフト 治 療




















Endovascular intervention for a dilated false lumen after repair of type B aortic 
dissection：case report
Akio YAMASHITA, Kanetsugu NAGAO, Masaya AOKI, Katsunori TAKEUCHI, and Naoki YOSHIMURA






　A ７8-year-old man underwent surgery for acute type B dissection ２５ years ago. However, the false 
lumen became patent postoperatively and was left unrepaired. The false lumen subsequently dilated, 
and thoracic endovascular aortic stent grafting was performed to stop blood flow. An aortic closure 
device was then used to successfully occlude the false lumen. This method may be effective when 
repeat surgery or thoracotomy would be difficult.
Key words: chronic type B dissection, TEVAR,  false lumen occlusion




ル で 遮 断 し，Y 型 人 工 血 管（１8x１０mm Hemashild: 
Maquet）に置換した。引き続き右総大腿動脈よりガイ




内 に カ ニ ュ レ ー シ ョ ン し， 大 血 管 閉 鎖 用device 




した（Fig. ３b, c）。手術時間は ３ 時間３8分であった。
　術後経過は良好であった。術後造影CTにて偽腔は造
影されなかった。術後 １ 年の造影CTでは偽腔は造影さ
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　 4 月１6日から ５ 月１５日までの約 １ カ月間，アメリカテネシー州にあるLe 

































































































られない数の心筋症の患者や左心低形成の患者を一度に診ることができた。また， ３ 週目にはLe Bonheur
で4０年近く勤務なさっている小児神経科の五十嵐先生という日本人医師がいらっしゃり，そちらの外来見学




















































　宿泊施設は留学生用の寮がないということで最初の １ 週間はホテルに宿泊していました。そして残りの ３
週間は病院の先生の知り合いの家に居候させていただきました。ホテルは ３ 人共同の部屋で １ 週間あたり一
人 4 万円程度で，キッチンやジム，プールなどが併設されていましたが， 4 週間宿泊するとなると高くなる
ため，後日先生の知り合いの方を紹介してもらい居候する形となりました。居候させていただいた家では一
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ローに付き添って見学させていただいた。仕事内容は心疾患を持つ患者さんの救急外来，病院全体の心疾患












































































　私はCardiologyの分野で １ か月間実習させていただきました。 １ か月間のスケジュールは現地のスタッフ
が組んで下さっており，朝のカンファレンスなどはその日の都合に合わせて自由に参加する形式でした。主






























　アメリカのオハイオ州にあるCincinnati Children’s Hospital Medical Center（CCHMC）で約 ３ 週間実習
させていただいたので報告したいと思います。
【実習内容】
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　実習は ３ グループに分かれて行いました。自分のペアーである現地学生と同じグループに所属し，実習を
行 いました。 実 習 場 所 は，Klinik Kesihatan Taman Ehsan（KKTE），Klinik Kesihatan Sungai Buioh
（KKSB），Selayang Campus（SC）の ３ キャンパスがあり，その日によって実習場所が変わります。SC以
外のキャンパスは距離が離れているので現地の学生が車で送迎してくれました。そのため，実習するキャン
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201６年度海外臨床実習報告
実習先：UniversitiTeknologiMARA（UiTM）







↓ ５ 年生の夏～秋頃:行き先をクラス内で仮決定（例年UiTMは ５ 名程度）
↓ ５ 年生秋頃:山城先生がUiTMの方に受け入れ確認をしてくださる
↓ ５  年生冬:学生（代表者）が具体的な日程や診療科についてUiTMの事務の方とメールで連絡






































ンギットを 用 意 する 必 要 はないと
思っていたのですが，日常生活
エリア内にVISA+対応のATMが無
かったので，観 光 に 連 れ 出 しても
らった時などにATMを見つけて必
要に応じて引き出しました。











１ つの共有スペースを使用する構造ですので， ２ 人と ３ 人に分












































　実 習 では，4０人 がさらに１３-１4人 の ３ グループに 分 かれて 各 クリニックを 回ったりグループディスカッ
ションを行ったりします。我々のBuddyもいずれかのグループに属していますので，そのグループの実習に
参加させてもらいました。　普段の実習（プライマリ・ケア）では基本的に 8 ：００～ ９ ：００開始ですが，車
で移動しなければならない場合もあるので，その場合には早く出なければなりません。具体的には， Sg 









た。 扱 っ た テ ー マ は「Dizziness」，「Red 













　Teluk intan Hospital は感染症科で回る病院ですが，現地の学生の尽力により，他ポスティングである感
染症科の実習にも参加させて頂くことができました。感染症科の実習に私は ３ 日間参加しました。内 １ 日は
５ 人全員参加の日帰り， ２ 日は希望者 ３ 人がTeluk intan の宿舎に １ 泊しての参加となりました。寮のある
Selayang Campusから 車 で ２ 時 間 ほどかかりますが，チャンスがあれば 是 非 行 くことをお 勧 めします。






















UiTMのDr. Hashidah（プライマリ・ケア），Dr. Punithavathy （プライマリ・ケア），Dr. Yazli（感染症科）， 
Dr. Masri（小児科），Mr.Farizul（事務），学生のみなさんには深く感謝します。ありがとうございました。
Dr.YazliとLumutにて










































































































































Sungai Buloh）があり， ３ つのクリニックと １ つの病院があります。私たちは昨年，一昨年と同じくクアラ
ルンプール（KL）のSelayangキャンパスの学生寮にお世話になりました。キャンパスから道路を挟んで向
かい側には，セブンイレブンがあります。さらに今年の初めにキャンパスの隣に（徒歩 ５ 分ほど）大きな
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選択制海外臨床実習報告（ドイツ）

































　 １ 件目の手術が終わったらお昼を食べ，午後から ２ 件目の手術を見学します。手術が終わって帰宅するの


















































































　 4 週間のうち， ３ 週間を小児心臓外科で， １ 週間を循環器小児科で実習させて頂きました。外科では小児





























　このたび，医学教育振興財団（JMEF）による英国医学部短期留学のプログラムを通じて２０１6年 6 月 6 日
から ７ 月 １ 日 にかけ，リーズ 大 学 医 学 部 の 教 育 病 院 であるLeeds General Infirmary（LGI）ならびにSt. 
James University Hospital （SJUH）で実習させていただきました。今回このような貴重な機会をいただき，
私たちの実習を実現させるために関わってくださったすべての方々に心から感謝しております。
2 ．UniversityofLeedsTeachingHospitalsについて
　リーズ大学医学部にはLeeds General Infirmary（LGI）とSt. James University Hospital（SJUH）という
２ つの教育病院（University of Leeds Teaching Hospitals）があります。診療科によってどちらの病院に所
属するかは変わるのですが，私が実習を希望した産婦人科は両方の病院にそれぞれユニットがあり，両方の









































　その他にも，胎児診断・治療を専門にしているDr. BreezeのFetal medicine clinicには毎週通わせていた
だきました。日本で胎児診療・治療を見学したことはなかったのですが，エコーを片手に胎児と会話するか
のように正常・異常を探しに行くことの面白さの虜になり，私も将来何かしらの形で胎児診療に関わりたい
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第 8 条　本会の事業年度は，年度制による。
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1　Introduction
　Toyama Medical Journal is the official publication of 
the University of Toyama medical association.
2　Typesofpapers
　Reviews, original articles, case series, case reports, 
short communications and meeting abstracts held in 
and around Toyama prefecture will be considered.
３　Formattingguidelines
a)Articlestructure
　Papers should be set out in the following order: title 
page, abstracts, text, references, tables and figures. The 
data and two sets of printed manuscripts must be sent 
to the editorial office.  Manuscripts which are written 
by non-native English writer must be proofread by 
language services and required to provide a certificate 
in proofreading. 
b)Formatofprintedout
　Manuscripts should be written by use of 
wordprocessing software. Text should be written in 
double-spaced. The number of tables and figures is up 
to five in total.
c)Titlepage
　The title page must have the category of the article 
(for example “original article”), the complete title of the 
paper, name(s) of author(s), affiliation(s) , key words(up 
to five), running title, number of pages of text, number 
of tables and figures, order of reprints (５０ copies in a 
unit).
d)Abstract
　Abstract must be written in ２００ words and printed in 
double-spaced.
e)Text
　Authors should use the following subheadings to 
divide the sections of their manuscript: Introduction, 
Materials and Methods, Results and Discussion. Heading 
in the text must be written as follows.
I, II, ……,  A, B, ……,  １, ２, ……,  a, b, ……, 
(１), (２), …….
　Acknowledgments should be placed at the last section 
of the text.
f)Scientificnames
　Scientific names should be underlined.
g)Abbreviationsandunits
　All abbreviations should be fully explained at their 
first occurrence in the text. 
　All measurements should be expressed in metric 
units, SI units.
[Length] m, cm, mm, μm, nm, Å
[Weight] kg, g, mg, μg
[Square] m２, mm２
[Cubic measure] m３, cm３ , mm３
[Volume] l, ml, μl
[Mole number and concentration] mol, mmol, μmol, 
nmol, pmol, M(mol/L), Eq, N(normal), %
[Time] d, h, min, s, ms, μs
[Temperature] ℃
[Pressure] mmHg, mber
[Electricity] V(volt), A(ampere), Hz(cycles/sec)
[Radiation] Ci, cpm, r
[Optical isomer] d-, l-, dll
[Administration] iv, ip, im, sc, po
[Statistics] SD, SEM
[Others] g(gravity), LD５０, ED５０ 
h)Reference
　In the text, references should be cited using 
superscript Arabic numerals in the order in which they 
appear. If the work has equal to or more than five 
authors, list the first three authors followed by et al. 
The reference list should be written following the 
examples given below. Journal names should be 
abbreviated according to INDEX MEDICUS (http://
www２.bg .am.poznan .p l/czasop isma/medicus .
php?lang=eng).
Journalarticles
１)  Kimimura K., Takatsu T. and Ahmed A.: A survey 
of mosquitoes in Karachi area, J Pak Med Assoc. 
３6: １8１-１88, １９86.
Book
２)  Nakata T. and Katayama T.: Changes in human 
adrenal catecholamines with age. In: Urology 
(Jardan A. ed.)  : 4０4-4０6. International B’Urologie, 
Paris, １９86. 
i)Figuresandtables
　All figures and tables should be cited in text in 
Toyama Medical Journal
Instructions for Authors
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consecutive numerical order. The printout of them 
should be attached in order after the last page of the 
text. Each table and figure should not extend beyond 
one page.
4　Peerreviewandacceptance
　Every article has been peer reviewed. Acceptances 
are decided by editorial board of the University of 
Toyama medical association.
5　Proofreading
　The purpose of the proof is to check for typesetting 
or conversion errors. Substantial changes in content are 
not allowed without the approval of the editor
6　Publicationchargesandreprints
　Page charges: ¥ ５,０００ for a page up to six pages, ¥ 
９,０００ for a page from seven to ten pages. When the 
paper has more than １０ pages, the charges of reprints 
(included postage charges) are informed through a 
charge sheet. Color prints are available for extra 
charges.
7　Submissionofmanuscripts
　Authors should send the manuscript files and prints 
to the Editorial Office of Toyama Medical Journal.
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３ 　執 筆 規 定　以下の規定に従う。























































文 ではet al．）とする。とくに 句 読 点 に 注 意 す
る。　
　　和文原著文献
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6 　掲載料，別刷費用　本文・図表を含め刷り上り 6 頁
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